The ML team has a dataset. The dataset has the right labels, the right schema, the right volume. And they can't use it. Not because it's low quality — because it contains real patient records, and the governance rules that apply to those records block every path to the training environment. This is a more common engineering constraint than people outside healthcare or financial services realize, and the solutions matter.
What privacy constraints actually block
HIPAA's minimum necessary standard and de-identification rules (45 CFR §164.514) don't prohibit using patient data for internal ML development, but in practice the operational constraints often do. Moving records to a cloud ML platform triggers BAA requirements, logging requirements, and access control audits that slow down experimentation cycles significantly. Many teams end up with real data that's technically accessible but operationally blocked — sitting in a protected enclave that can't connect to the development tooling.
GDPR introduces a different set of constraints for European patient and customer data. Article 5's purpose limitation means data collected for clinical care may not be freely repurposable for ML model training without explicit consent or a compatible lawful basis. Article 17 deletion obligations mean your training dataset may shrink over time as records are removed. Building a stable training pipeline on top of GDPR-scoped data requires legal review that most engineering teams don't have the bandwidth to run continuously.
Enterprise data governance adds a third layer: even when data is internally owned and legally usable, organizations often have internal data classification policies that prevent certain record types from leaving specific systems or being accessed by teams without specific clearance. The ML team may have clearance to query production data for reporting, but not to export it for model training.
De-identification is not as simple as masking PII fields
The standard first attempt is field-level de-identification: remove the name, SSN, date of birth, address. HIPAA's Safe Harbor method identifies 18 specific data elements to remove. This approach has a known problem: re-identification risk from the remaining fields, especially when records contain combinations of rare attributes. A patient record with a rare diagnosis, a specific geographic region, and an unusual age/comorbidity combination can be re-identified from public sources even after Safe Harbor de-identification.
The expert determination method (45 CFR §164.514(b)(1)) allows a qualified statistician to certify that re-identification risk is sufficiently low — but this is an expensive and time-consuming process, and it produces a binary certification for a specific dataset rather than a reusable framework for ongoing model development.
k-anonymity and its extensions (l-diversity, t-closeness) are more principled approaches: they ensure that any individual record in the published dataset is indistinguishable from at least k-1 other records on a set of quasi-identifier attributes. But achieving k-anonymity on high-dimensional tabular data requires significant information loss — generalizing or suppressing values — which degrades the statistical utility of the data for model training.
Privacy-by-construction: a different architecture
Synthetic generation offers a different architecture for this problem. Instead of de-identifying real records, you model the statistical structure of real records and generate new records that have never existed. The generator learns marginal distributions and pairwise correlations from a real sample, then produces rows that share statistical properties with real data without being derived from any specific real record.
The key property is that no individual in the real dataset corresponds to any row in the synthetic output. This is qualitatively different from de-identification: de-identification tries to remove identifying information from real records (and may fail if residual quasi-identifiers allow re-identification); synthetic generation never starts with the real record in the output at all.
We describe this as "privacy by construction" rather than making compliance claims. Whether synthetic data satisfies HIPAA de-identification requirements in a specific context is a legal determination, not a technical one. What we can say technically is that the output contains no real records, and the nearest-neighbor distance between any synthetic record and any real record can be measured and reported. We're not saying synthetic generation is a compliance solution — we're saying it removes the real records from your training pipeline, which changes the governance question your legal team needs to answer.
Validating that synthetic data doesn't leak
After generation, the question is: how do you verify that the synthetic data doesn't inadvertently expose information about real records? The standard technical approach is distance-based validation. For each synthetic record, compute the distance to the nearest real record in the training data (using an appropriate distance metric for mixed-type tabular data — Gower distance or similar). If the minimum nearest-neighbor distance is very small, it suggests the generator memorized specific real records rather than learning a generalizable distribution.
We surface this as a privacy score in Twynvex's quality reports: the 5th percentile nearest-neighbor distance, normalized against expected random distances for the same feature space. A score above threshold indicates the synthetic data is not closely tracking any specific real records. This isn't a guarantee — it's a diagnostic that gives teams evidence to work with when making internal governance decisions about data usage.
Membership inference attacks are a more adversarial validation: train a classifier to distinguish "was this record used in training the generator?" The attack success rate gives you a measure of how much information about individual training records is retained in the generator's parameters. For well-regularized generators, this attack should perform near chance. If it performs significantly above chance, the generator has overfit to specific training examples and synthetic data derived from it may carry re-identification risk.
Practical path through the constraint
The pattern that tends to work in practice: run generation inside the same controlled environment where the real data lives. The generator runs in the protected enclave, learns from the real records without exporting them, and produces a synthetic dataset. That synthetic dataset — which contains no real records — can then move to the development environment where real data wasn't permitted.
This doesn't eliminate the need for data governance review — it changes the governance question. Instead of "can ML engineers access patient records?" the question becomes "can this synthetic dataset, with documented privacy properties, be moved to the development environment?" That's often a narrower question with a faster answer.
The teams that have found this most useful tend to be smaller ML groups working in regulated verticals: a data science team building risk models at a mid-size financial institution where compliance reviews on data access take weeks; a clinical analytics group that wants to run experiments in the cloud but can't move patient records outside the on-premises environment. The constraint is real, the workaround using real de-identification is expensive, and synthetic generation provides a path that doesn't require either defeating the governance rules or abandoning the experiment.